FORM 6-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
| | For the month ended | | Commission File Number | |
| | November 2007 | | 1-32608 | |
| | VIREXX MEDICAL CORP. | |
| | (Translation of registrant's name into English) | |
| | 8223 Roper Road NW, Edmonton, Alberta, Canada T6E 6S4 | |
| | (Address of principal executive offices) | |
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F X Form 40-F .....
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ..... No ..X..
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ________
EXHIBIT LIST
| Exhibit | | Description |
| 99.1 | | Press Release Announcing Third Quarter Results |
| 99.2 | | Interim financial statements for the nine month period ended September 30, 2007 |
| 99.3 | | Management’s Discussion and Analysis |
| 99.4 | | Certification of Chief Executive Officer and Chief Financial Officer |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | | |
| | VIREXX MEDICAL CORP. |
| | |
| Date: November 14, 2007 | By: | /s/ Brent Johnston |
| | Brent Johnston Chief Financial Officer |
| | |
